A new scientific paper by Dr. Hodaka Fujii, the Founder and CSO of the company, has been published.

News
19 Aug 2021

A new paper was published today by Hodaka Fujii, M.D., Ph.D., the Founder and Director, CSO of Epigeneron, Inc., simultaneously serving as Professor at Hirosaki University, and his team, entitled “Protein or ribonucleoprotein-mediated blocking of recombinase polymerase amplification enables the discrimination of nucleotide and epigenetic differences between cell populations”.
Please refer to the link below for more details.

https://www.nature.com/articles/s42003-021-02503-5